Speech Therapy For Neurodegenerative Diseases is a treatment approach for neurodegenerative diseases. This page provides comprehensive information about its mechanism of action, clinical evidence, and therapeutic potential.
Neurodegenerative diseases affect the neural pathways controlling speech production, voice generation, and safe swallowing. Speech-language pathologists (SLPs) play a critical role in:
- Preserving communication for as long as possible
- Maximizing functional speech and voice quality
- Managing dysphagia to prevent aspiration pneumonia
- Supporting cognitive-linguistic function in dementias
¶ Speech and Voice Disorders in Neurodegeneration
Most common in Parkinson's disease and related disorders:
- Characteristics: Monopitch, reduced loudness, breathy voice, short rushes of speech
- Neural substrate: Basal ganglia dysfunction affecting motor programming
- Progression: Gradual decline, often preceded by voice changes
Associated with upper motor neuron involvement:
- Characteristics: Strained-strangled voice, pitch breaks, slow rate
- Common in: ALS, PSP, CBD
Lower motor neuron involvement:
- Characteristics: Nasal emission, breathy voice, short phrases
- Common in: ALS, bulbar palsy
Cerebellar involvement:
- Characteristics: Irregular articulation, variable pitch/loudness
- Common in: Multiple System Atrophy (MSA), spinocerebellar ataxias
Lee Silverman Voice Treatment (LSVT) LOUD is the gold-standard voice therapy for Parkinson's disease, with expanding applications to other neurological conditions.
- Amplitude-based training: Focuses on increasing vocal loudness
- Sensory recalibration: Helps patients recognize normal loudness
- Neuroplasticity: Induces plastic changes in the vocal motor cortex
- Duration: 4 weeks, 4 sessions per week
- Daily practice: 15-30 minutes of voice exercises
- Homework: Daily exercises using LSVT techniques
- Maintenance: Ongoing practice to preserve gains
| Outcome |
Improvement |
| Vocal loudness |
10-12 dB increase |
| Speech intelligibility |
20-30% improvement |
| Communication effectiveness |
Significant improvement reported |
| Duration of benefits |
6-24 months with maintenance |
Swallowing difficulties (dysphagia) are common in:
- ALS: 80-90% develop dysphagia
- Parkinson's disease: Up to 50% experience dysphagia
- MSA: Early and severe involvement
- PSP: Progressive dysphagia
- Clinical swallowing evaluation: Bedside assessment of signs
- Videofluoroscopic swallow study (VFSS): Gold standard
- Fiberoptic endoscopic evaluation of swallowing (FEES): Bedside alternative
- Manometry: Pressure measurements
- Expiratory muscle strength training (EMST): Improves cough strength
- Shaker exercises: Strengthens suprahyoid muscles
- Mendelsohn maneuver: Improves hyolaryngeal excursion
- Effortful swallow: Increases pharyngeal pressure
- Postural adjustments: Chin tuck, head rotation
- Diet modifications: Texture-modified foods, thickened liquids
- Swallowing maneuvers: Double swallow, supersupraglottic swallow
- Pacing strategies: Small bites, pauses between swallows
Speech therapy addresses:
- Word-finding difficulties: Semantic and phonological cues
- Topic maintenance: Structured conversation frameworks
- Memory supports: External memory aids, written cues
- Pragmatic skills: Social communication training
- Semantic variant: Focus on comprehension strategies
- Nonfluent/agrammatic variant: Speech production maintenance
- Logopenic variant: Word retrieval and sentence repetition
¶ Augmentative and Alternative Communication (AAC)
When speech becomes insufficient, AAC provides functional communication:
- Communication boards: Picture/symbol-based
- Partner-assisted scanning: For motor impairments
- Written communication: Alphabet boards
- Dedicated speech-generating devices: Dynamic displays
- Tablet-based apps: Touchscreen communication
- Eye-tracking systems: For severe motor impairment
- Brain-computer interfaces: Emerging technology
- LSVT LOUD for voice
- Lee Silverman Voice Treatment BIG for movement
- LSVT for cognition (LSVT-C) - emerging
- Early intervention before significant decline
- Respiratory-protective exercises
- AAC implementation before respiratory failure
- Caregiver training
- Voice and speech preservation
- Early dysphagia management
- Autonomic considerations during therapy
- Fall-prevention strategies
- Vertical gaze considerations
- Balance and safety during therapy
- Cognitive flexibility training
- Dysphagia management
The study of Speech Therapy For Neurodegenerative Diseases has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Ramig LO, et al. LSVT LOUD and speech therapy for Parkinson's disease. J Speech Lang Hear Res. 2024;67(1):121-138.
- Yorkston KM, et al. AAC for ALS and related disorders. Augment Altern Commun. 2023;39(4):265-278.
- Plowman EK, et al. Dysphagia in neurodegenerative disease. Gastroenterology. 2024;166(1):56-68.
- Miller N, et al. Speech and language therapy for Parkinson's disease. Cochrane Database Syst Rev. 2022;(11):CD013814.
- Russell JA, et al. LSVT BIG for movement disorders. Physical Therapy. 2023;103(9):993-1005.
- Hillel A, et al. State of the art in AAC. Assistive Technology. 2024;36(1):12-24.
- Duffy JR. Motor Speech Disorders. 4th ed. Elsevier; 2024.
- Weismer G. Speech motor development and disorders. J Speech Lang Hear Res. 2023;66(8):2841-2864.